CYRX Dec 2024 25.000 call
| Previous close | 0.3000 |
| Open | 1.6000 |
| Bid | 0.0000 |
| Ask | 0.7500 |
| Strike | 25.00 |
| Expiry date | 2024-12-20 |
| Day's range | 0.3000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 39 |
PR NewswireCryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and Minaris Regenerative Medicine Co., Ltd. ("Minaris"), a global contract development and manufacturing organization for cell and gene therapies, today announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies.
GuruFocus.comInsider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
On May 15, 2024, Richard Berman, Director of CryoPort Inc (NASDAQ:CYRX), executed a sale of 8,105 shares of the company, according to the SEC Filing.
Simply Wall St.Cryoport, Inc.'s (NASDAQ:CYRX) CEO Compensation Looks Acceptable To Us And Here's Why
Key Insights Cryoport to hold its Annual General Meeting on 17th of May Salary of US$865.6k is part of CEO Jerry...
